Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$0.87 - $2.11 $17,400 - $42,200
-20,000 Reduced 17.86%
92,000 $80,000
Q4 2022

Feb 14, 2023

BUY
$0.89 - $28.0 $29,370 - $924,000
33,000 Added 41.77%
112,000 $106,000
Q3 2022

Nov 14, 2022

BUY
$1.06 - $27.5 $23,320 - $605,000
22,000 Added 38.6%
79,000 $87,000
Q2 2022

Aug 15, 2022

BUY
$1.04 - $2.14 $59,280 - $121,980
57,000 New
57,000 $69,000

Others Institutions Holding ALGS

About Aligos Therapeutics, Inc.


  • Ticker ALGS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,717,000
  • Market Cap $751M
  • Description
  • Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB);...
More about ALGS
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.